EDAP TMS reported EUR5.97M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
AngioDynamics USD 44.78M 2.93M Sep/2025
Boston Scientific USD 3.68B 136M Dec/2025
EDAP TMS EUR 5.97M 850K Sep/2025
Henry Schein USD 1.06B 37M Dec/2025
Medtronic USD 5.41B 27M Dec/2025
Plus Therapeutics 1.37M 30K Dec/2025
Veracyte USD 101.97M 10.69M Dec/2025